R. W. Gould

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot”.

Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot

JCI Insight(2023)10.1172/jci.insight.175785

N/A

0DataRank · unranked

19 citations

Monty B. Mazer, Patrick W. McGonagill, Christian B. Bergmann, Michael D. Goodman, R. W. Gould +35 more

Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γ ELISpot: A Multicenter, Prospective Observational Study

medRxiv(2023)10.1101/2023.09.13.23295360

N/A

0DataRank · unranked

4 citations

Monty B. Mazer, Patrick W. McGonagill, Christian B. Bergmann, Michael D. Goodman, R. W. Gould +34 more

Development and optimization of a diluted whole blood ELISpot assay to test immune function

Journal of Immunological Methods(2024)10.1016/j.jim.2024.113743

N/A

0DataRank · unranked

4 citations

Julie Xu, Tamara A. Kucaba, Mahil Rao, Christian B. Bergmann, Scott C. Brakenridge +14 more

Determining potential immunomodulatory drug efficacy in sepsis using ELISpot

Scientific Reports(2025)10.1038/s41598-025-92016-6

N/A

0DataRank · unranked

7 citations

Monty B. Mazer, Kenneth E. Remy, Dale F. Osborne, Ethan Davitt, Thomas S. Griffith +12 more

Development and optimization of a diluted whole blood ELISpot assay to test immune function

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.20.576465

N/A

0DataRank · unranked

1 citations

Julie Xu, Tamara A. Kucaba, Mahil Rao, Scott C. Brakenridge, Philip A. Efron +11 more